Hepatocyte growth factor activator inhibitor type 1 (HAI-1) is required for the integrity of intestinal epithelium

被引：0
|
作者：
Kawaguchi, Makiko [1 ]
Fukushima, Tsuyoshi [1 ]
Takeda, Naoki [2 ]
Hoshiko, Shinri [1 ]
Yorita, Kenji [1 ]
Kohama, Kazuyo [1 ]
Orikawa, Hiroshi [1 ]
Baba, Takashi [1 ]
Kataoka, Hiroaki [1 ]
机构：
[1] Miyazaki Univ, Miyazaki, Japan
[2] Kumamoto Univ, Kumamoto, Japan
来源：
FASEB JOURNAL | 2010年 / 24卷
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Defect of Hepatocyte Growth Factor Activator Inhibitor Type 1/Serine Protease Inhibitor, Kunitz Type 1 (Hai-1/Spint1) Leads to Ichthyosis-Like Condition and Abnormal Hair Development in Mice
    Nagaike, Koki
    Kawaguchi, Makiko
    Takeda, Naoki
    Fukushima, Tsuyoshi
    Sawaguchi, Akira
    Kohama, Kazuyo
    Setoyama, Mitsuru
    Kataoka, Hiroaki
    [J]. AMERICAN JOURNAL OF PATHOLOGY, 2008, 173 (05): : 1464 - 1475
  • [32] Expression and a role of HGF activator inhibitor type-1 (HAI-1) in hepatocellular carcinoma
    Nagata, K
    Ido, A
    Kataoka, H
    Moriuchi, A
    Onaga, M
    Hori, T
    Hirono, S
    Hayashi, K
    Tsubouchi, H
    [J]. JOURNAL OF HEPATOLOGY, 2001, 34 : 101 - 101
  • [33] Augmented expression of hepatocytes growth factor activator inhibitor type 1 (HAI-1) in intrahepatic small bile ducts in primary biliary cirrhosis
    Sasaki, Motoko
    Ikeda, Hiroko
    Kataoka, Hiroaki
    Nakanuma, Yasuni
    [J]. VIRCHOWS ARCHIV, 2006, 449 (04) : 462 - 471
  • [34] Effect of HGF activator inhibitor type-1 (HAI-1) on cell growth of hepatoma cell lines.
    Nagata, K
    Ido, A
    Moriuchi, A
    Tahara, Y
    Miyata, Y
    Uto, H
    Hori, T
    Shimomura, T
    Kataoka, H
    Hirono, S
    Hayashi, K
    Tsubouchi, H
    [J]. HEPATOLOGY, 2000, 32 (04) : 483A - 483A
  • [35] Augmented expression of hepatocytes growth factor activator inhibitor type 1 (HAI-1) in intrahepatic small bile ducts in primary biliary cirrhosis
    Motoko Sasaki
    Hiroko Ikeda
    Hiroaki Kataoka
    Yasuni Nakanuma
    [J]. Virchows Archiv, 2006, 449 : 462 - 471
  • [36] Expression of hepatocyte growth factor activator and hepatocyte growth factor activator inhibitor type 1 in human hepatocellular carcinoma
    Nagata, K
    Hirono, S
    Ido, A
    Kataoka, H
    Moriuchi, A
    Shimomura, T
    Hori, T
    Hayashi, K
    Koono, M
    Kitamura, N
    Tsubouchi, H
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2001, 289 (01) : 205 - 211
  • [37] Hepsin activates pro-hepatocyte growth factor and is inhibited by hepatocyte growth factor activator inhibitor-1B (HAI-1B) and HAI-2
    Kirchhofer, D
    Peek, M
    Lipari, MT
    Billeci, K
    Fan, B
    Moran, P
    [J]. FEBS LETTERS, 2005, 579 (09) : 1945 - 1950
  • [38] The divergent roles of matriptase and HAI-1 in human hepatocyte and biliary duct epithelium
    Yeo, Yee Hui
    Lin, Chen-Yong
    Johnson, Michael
    [J]. HEPATOLOGY, 2017, 66 : 720A - 721A
  • [39] Subcellular distribution of hepatocyte growth factor activator inhibitor type 1 (HAI-1) in the full-term human placenta as revealed by ultrahigh-resolution immunofluorescence microscopy (UHR-IFM)
    Takizawa, T.
    Mori, M.
    Ishikawa, G.
    Goto, T.
    Kataoka, H.
    Takeshita, T.
    [J]. PLACENTA, 2006, 27 (9-10) : A51 - A51
  • [40] Hepatocytes growth factor activator type 1 (HAI-1) is augmented in intrahepatic small bile ducts in primary biliary cirrhosis
    Sasaki, M
    Ikeda, H
    Kataoka, H
    Nakanuma, Y
    [J]. HEPATOLOGY, 2005, 42 (04) : 468A - 468A
12345